Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 556
Filtrar
1.
Cardiovasc Diabetol ; 20(1): 75, 2021 03 31.
Artigo em Inglês | MEDLINE | ID: mdl-33789663

RESUMO

The 6th Cardiovascular Outcome Trial (CVOT) Summit "Cardiovascular and Renal Outcomes 2020" was the first to be held virtually on October 29-30, 2020. As in previous years, this summit served as reference meeting for in-depth discussions on the topic of recently completed and presented major outcome trials. This year, focus was placed on the outcomes of VERTIS-CV, EMPEROR-Reduced, DAPA-CKD, and FIDELIO-DKD. Trial implications for diabetes management and the impact on new treatment algorithms were highlighted for diabetologists, cardiologists, endocrinologists, nephrologists, and general practitioners. Discussion evolved from major outcome trials using SGLT-2 inhibitors for treatment and prevention of heart failure and chronic kidney disease in people with and without diabetes, to additional therapy options for chronic kidney disease with a novel mineralocorticoid receptor antagonist. Furthermore, challenges in diabetes management like COVID-19 and obesity, as well as novel treatment strategies and guidelines, were discussed.The 7th Cardiovascular Outcome Trial Summit will be held virtually on November, 18-19, 2021 ( http://www.cvot.org ).


Assuntos
/epidemiologia , Doenças Cardiovasculares/epidemiologia , Ensaios Clínicos como Assunto/métodos , Congressos como Assunto/tendências , Insuficiência Renal Crônica/epidemiologia , Relatório de Pesquisa/tendências , /terapia , Doenças Cardiovasculares/terapia , Diabetes Mellitus Tipo 2/epidemiologia , Diabetes Mellitus Tipo 2/terapia , Humanos , Rim/efeitos dos fármacos , Rim/fisiologia , Antagonistas de Receptores de Mineralocorticoides/administração & dosagem , Insuficiência Renal Crônica/terapia , Inibidores do Transportador 2 de Sódio-Glicose/administração & dosagem , Resultado do Tratamento
6.
Circ J ; 85(3): 323-329, 2021 02 25.
Artigo em Inglês | MEDLINE | ID: mdl-33518695

RESUMO

Due to the COVID-19 pandemic, the 84thAnnual Meeting of the Japanese Circulation Society (JCS) was held in a web-based format for the first time in its history as "The Week for JCS 2020" from Monday, July 27 to Sunday, August 2, 2020. All sessions, including general abstracts, were streamed live or on-demand. The main theme of the meeting was "Change Practice!" and the aim was to organize the latest findings in the field of cardiovascular medicine and discuss how to change practice. The total number of registered attendees was over 16,800, far exceeding our expectations, and many of the sessions were viewed by far more people than at conventional face-to-face scientific meetings. At this conference, the power of online information dissemination was fully demonstrated, and the evolution of online academic meetings will be a direction that cannot be reversed in the future. The meeting was completed with great success, and we express our heartfelt gratitude to all affiliates for their enormous amount of work, cooperation, and support.


Assuntos
Cardiologia/organização & administração , Congressos como Assunto/organização & administração , Sociedades Científicas/organização & administração , Telecomunicações/organização & administração , Cardiologia/tendências , Doenças Cardiovasculares/diagnóstico por imagem , Doenças Cardiovasculares/terapia , Congressos como Assunto/estatística & dados numéricos , Congressos como Assunto/tendências , Humanos , Japão , Pesquisa , Inquéritos e Questionários , Telecomunicações/estatística & dados numéricos , Telecomunicações/tendências
8.
J Thorac Cardiovasc Surg ; 161(3): 733-744, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-33431207

RESUMO

BACKGROUND: Increased attention has been dedicated to gender inequity at scientific meetings. This study evaluated the gender distribution of session leaders at cardiothoracic surgery national and regional meetings. METHODS: This is a descriptive study of the gender of peer-selected session leaders at 4 cardiothoracic surgery organizations' annual meetings from 2015 to 2019. Session leaders included moderators, panelists, and invited discussants. Data from publicly available programs were used to generate a list of session leaders and organization leaders. The primary outcome measure was the proportion of female session leaders at annual meetings. Descriptive analyses were performed, including the Cochran-Armitage trend test for linear trends of proportions. RESULTS: A total of 679 sessions over 20 meetings were examined. Of the 3662 session leaders, 480 (13.1%) were women. The proportion of total female session leaders trended positively over time from 9.6% (56 of 581) in 2015 to 15.9% (169 of 1060) in 2019 (P = .001). Among specialty topic sessions, female session leaders were distributed as follows: adult cardiac, 6.9% (81 of 1172); congenital cardiac, 10.8% (47 of 437); and thoracic, 23.2% (155 of 668). The proportion of female session leaders trended significantly only for thoracic sessions (20.6% [21 of 102] in 2015 to 29.2% [58 of 199] in 2019; P = .02). More than one-half of the sessions (57.4%; 390 of 679) featured all-male session leadership. CONCLUSIONS: Women remain underrepresented in leadership roles at cardiothoracic surgery organizational meetings. This may deter female applicants and has implications for female surgeons' career trajectories; therefore, attention must be given to the potential for unconscious bias in leadership in cardiothoracic surgery.


Assuntos
Congressos como Assunto/tendências , Equidade de Gênero , Liderança , Médicas/tendências , Cirurgiões/tendências , Cirurgia Torácica/tendências , Procedimentos Cirúrgicos Torácicos/tendências , Procedimentos Cirúrgicos Cardíacos/tendências , Diversidade Cultural , Feminino , Humanos , Masculino , Sexismo , Fatores de Tempo
10.
Support Care Cancer ; 29(4): 1713-1718, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33484357

RESUMO

This paper chronicles the third decade of MASCC from 2010. There was a generational change in this decade, building on the solid foundation of the founders. It included the first female President, and a new Executive Director with a background in strategy and business development and operations as applied to healthcare. The headquarters moved from Copenhagen to Toronto. The first meeting to be held outside of Europe or North America was held in Adelaide, Australia, and the membership in the Asia Pacific region expanded. A program of international affiliates saw national supportive care organisations formally link with MASCC. In cancer supportive care, there was a raft of new toxicities to manage as immunotherapies were added to conventional cytotoxic treatment. There was also a greater emphasis on the psychosocial needs of patients and families. New MASCC groups were formed to respond to this evolution in cancer management. The MASCC journal, Supportive Care in Cancer, continued to grow in impact, and MASCC published two editions of a textbook of supportive care and survivorship. The decade ended with the challenge of the COVID-19 pandemic, but that served to highlight the importance of good supportive care to patients with cancer.


Assuntos
Neoplasias/terapia , Cuidados Paliativos/história , Cuidados Paliativos/tendências , Sociedades Médicas/história , /epidemiologia , Congressos como Assunto/história , Congressos como Assunto/tendências , Conselho Diretor/história , Conselho Diretor/tendências , História do Século XX , História do Século XXI , Humanos , Agências Internacionais/história , Agências Internacionais/organização & administração , Agências Internacionais/normas , Agências Internacionais/tendências , Cooperação Internacional/história , Neoplasias/história , Cuidados Paliativos/organização & administração , Pandemias , Publicações/história , Publicações/tendências , Sociedades Médicas/organização & administração , Sociedades Médicas/normas , Sociedades Médicas/tendências
12.
J Exp Med ; 217(9)2020 09 07.
Artigo em Inglês | MEDLINE | ID: mdl-32735327

RESUMO

COVID-19 abruptly halted scientific conferences and seminars in mid-March, forcing the scientific community to either postpone or adapt to a virtual format. We caught up with Carla V. Rothlin, Elina I. Zúñiga, Hongbo Chi, Rino Rappuoli, and Matthew Krummel to find out about the pros and cons of virtual conferences and seminars and how these could change the nature of scientific conferences. Carla (CVR) and Elina (EIZ) established Global ImmunoTalks in April this year; Hongbo (HC) helped organize the Immunometabolism Mini-Symposia series in May and June; Rino (RR) was one of the scientific organizers of the Transforming Vaccinology Keystone, which moved to a virtual format in June; and Matthew (MK) has been organizing Eco Seminars at the University of California, San Francisco since 2019.


Assuntos
Infecções por Coronavirus/epidemiologia , Pneumonia Viral/epidemiologia , Telecomunicações/tendências , Betacoronavirus , Pesquisa Biomédica/tendências , California , Comunicação , Congressos como Assunto/tendências , Humanos , Pandemias , Pesquisadores , Software
16.
Br J Cancer ; 123(5): 698-699, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32704177

RESUMO

The COVID-19 pandemic resulted in the cancellation or postponement of traditional face-to-face scientific conferences, necessitating a rapid change in the way new discoveries in cancer were shared with the cancer research community. Here I present personal reflections on the upsurge of virtual cancer conferences, discussing their pros and cons in the context of traditional face-to-face deliveries.


Assuntos
Betacoronavirus , Pesquisa Biomédica/tendências , Congressos como Assunto/organização & administração , Congressos como Assunto/tendências , Infecções por Coronavirus/epidemiologia , Pneumonia Viral/epidemiologia , Infecções por Coronavirus/tratamento farmacológico , Infecções por Coronavirus/prevenção & controle , Infecções por Coronavirus/virologia , Descoberta de Drogas , Humanos , Pessoal de Laboratório Médico/psicologia , Neoplasias/terapia , Oncologistas/psicologia , Pandemias/prevenção & controle , Pneumonia Viral/tratamento farmacológico , Pneumonia Viral/prevenção & controle , Pneumonia Viral/virologia , Quarentena/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...